Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference66 articles.
1. Reichert, J. M. (2008). Monoclonal antibodies as innovative therapeutics. Current Pharmaceutical Biotechnology, 9, 423–430.
2. Reichert, J. M., Rosensweig, C. J., Faden, L. B., & Dewitz, M. C. (2005). Monoclonal antibody successes in the clinic. Nature Biotechnology, 23, 1073–1078.
3. Rodrigues, M. E., Costa, A. R., Henriques, M., Azeredo, J., & Oliveira, R. (2013). Advanced and drawbacks of adaptation to serum-free culture of CHO-K1 cells for monoclonal antibody production. Applied Biochemistry and Biotechnology, 169, 1279–1291.
4. Nelson, A. L., Dhimolea, E., & Reichert, J. M. (2010). Development trends for human monoclonal antibody therapeutics. Nature Reviews Drug Discovery, 9, 767–774.
5. Farid, S. S. (2008). Economic drivers and trade-offs in antibody purification processes. BioPharm International, 21, 37–42.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献